Key Financial Data Of Reporting Company

SUSMED, Inc. - Filing #7351363

Concept 2023-07-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-06-30
2022-07-01 to
2023-06-30
2022-07-01 to
2022-12-31
As at
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Ordinary profit (loss)
-90,767,000 JPY
-44,318,000 JPY
-187,766,000 JPY
Profit (loss)
-91,397,000 JPY
-50,749,000 JPY
-190,450,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
69,781,000 JPY
40,951,000 JPY
24,703,000 JPY
Total number of issued shares
16,685,800 xbrli:shares
16,622,500 xbrli:shares
16,438,400 xbrli:shares
Net assets
4,841,547,000 JPY
4,870,797,000 JPY
4,694,688,000 JPY
Total assets
5,172,011,000 JPY
5,101,124,000 JPY
4,891,214,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-5.49
3.29
-3.09
-11.68
-5.96
Diluted earnings per share
Equity-to-asset ratio
0.933 xbrli:pure
0.953 xbrli:pure
0.959 xbrli:pure
Net cash provided by (used in) operating activities
21,447,000 JPY
100,591,000 JPY
-93,546,000 JPY
Net cash provided by (used in) investing activities
-3,697,000 JPY
-18,189,000 JPY
-14,881,000 JPY
Net cash provided by (used in) financing activities
15,061,000 JPY
62,362,000 JPY
30,058,000 JPY
Cash and cash equivalents
5,081,649,000 JPY
5,048,838,000 JPY
4,825,705,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.